LEMAITRE VASCULAR INC·4

Feb 6, 4:48 PM ET

Roberts David B 4

4 · LEMAITRE VASCULAR INC · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Lemaitre Vascular (LMAT) President David Roberts Exercises Options

What Happened

  • David B. Roberts, President and Director of Lemaitre Vascular (LMAT), exercised vested stock options on 2026-02-05. He acquired 2,672 shares at an exercise price of $37.29 (cost $99,639) and 7 shares at $48.60 (cost $340), for a total of 2,679 shares and total cash paid of $99,979. The filing records the original derivative option interests as disposed (cancelled) in connection with the exercises (reported at $0.00).

Key Details

  • Transaction date: 2026-02-05 (reported on Form 4 filed 2026-02-06)
  • Prices and quantities: 2,672 shares @ $37.29 ( $99,639 ); 7 shares @ $48.60 ( $340 ); combined 2,679 shares, $99,979 paid
  • SEC transaction code: M = Option exercise/conversion
  • Shares owned after transaction: Not specified in the Form 4 provided
  • Footnotes: F1 — shares reported as acquired upon exercise; F2 — the option was fully vested and exercisable
  • Filing timeliness: Reported the next day (appears timely; no late filing indicated)

Context

  • These were option exercises (not open-market sales); the filing does not show any immediate sale of the acquired shares (i.e., not a cashless exercise reported). Exercising vested options converts the option (a derivative) into common shares and cancels the option interest.

Insider Transaction Report

Form 4
Period: 2026-02-05
Roberts David B
DirectorPresident and Director
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-05$37.29/sh+2,672$99,63924,923 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-05$48.60/sh+7$34024,930 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F2]
    2026-02-052,6720 total
    Exercise: $37.29From: 2020-12-02Exp: 2027-12-02Common Stock (2,672 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F2]
    2026-02-05714,054 total
    Exercise: $48.60From: 2021-12-11Exp: 2028-12-11Common Stock (7 underlying)
Footnotes (2)
  • [F1]Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
  • [F2]This option is fully vested and exercisable.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-02-06

Documents

1 file
  • 4
    ownership.xmlPrimary

    4